Weill Cornell Medicine Events

Molecular Pharmacology and Chemical Biology Program 

The Mevalonate Pathway: a Rational Target To Enhance Efficacy of BH3 Mimetics in Blood Cancer


        David Fruman, Ph.D


        Professor, Department of Molecular Biology & Biochemistry

        Associate Director, Cancer Research Institute

        Speaker's Affiliation:   University of California, Irvine


        Host:  Dr. Michael Kharas


        Tea ?:   Yes

        Tea Time:    Tea at 3:45 PM



Wednesday, September 26, 2018 at 4:00pm to 5:00pm

NewYork-Presbyterian Hospital/Weill Cornell Medical Center, M107
525 E 68th St.

Event Type



Education, Research

Google Calendar iCal Outlook

Recent Activity